Are patients with RA at increased risk of malignancy?

被引：1
|
作者：
Hyrich, Kimme L. [1 ,2 ]
机构：
[1] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England
[2] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
NATURE CLINICAL PRACTICE RHEUMATOLOGY | 2008年 / 4卷 / 12期
关键词：
anti-TNF; cancer; meta-analysis; rheumatoid arthritis;
D O I：
10.1038/ncprheum0924
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Recently, Smitten and colleagues conducted a meta-analysis of the risk of cancer in patients with rheumatoid arthritis ( RA) compared with that in the general population. The authors found no important differences in the overall risk of cancer in patients with RA. However, the risk of lymphoma and lung cancer seemed to be increased, whereas colorectal cancer and breast cancer risk was decreased. With recent changes in the therapeutic approach to RA, concern has been raised about the role of anti-tumor necrosis factor therapies in inducing or increasing the risk of lymphoma and other malignancies. However, it is important to consider the baseline risk of these malignancies in patients with RA when placing the risk of new therapies into context.
引用
收藏
页码：632 / 633
页数：2
相关论文
共 50 条
  • [21] INCREASED RISK OF OSTEOPOROSIS AND FRACTURE IN PATIENTS WITH SSc. A COMPARISON TO RA
    Avouac, J.
    Koumakis, E.
    Toth, E.
    Meunier, M.
    Maury, E.
    Cormier, C.
    Kahan, A.
    Allanore, Y.
    RHEUMATOLOGY, 2012, 51 : 111 - 112
  • [22] No increased cancer risk with biologics in RA
    Reactions Weekly, 2012, 1419 (1) : 3 - 3
  • [23] No Increased Risk of Incidence Diabetes in Patients with Rheumatoid Arthritis Compared to Patients Without RA
    Jin, Yinzhu
    Chen, Sarah
    Liu, Jun
    Desai, Rishi
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] Improved treatment strategies reduce the increased mortality risk in early RA patients
    van Nies, Jessica A. B.
    de Jong, Zuzana
    van der Helm-van Mil, Annette H. M.
    Knevel, Rachel
    Le Cessie, Saskia
    Huizinga, Tom W. J.
    RHEUMATOLOGY, 2010, 49 (11) : 2210 - 2216
  • [25] Thymoma is associated with an increased risk of second malignancy
    Pan, CC
    Chen, PCH
    Wang, LS
    Chi, KH
    Chiang, H
    CANCER, 2001, 92 (09) : 2406 - 2411
  • [26] No increased malignancy risk in psoriatic arthritis (PsA).
    Rohekar, Sherry
    Tom, Brian D. M.
    Hassa, Agnes
    Farewell, Vernon T.
    Schentag, Cathy T.
    Gladman, Dafna D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S723 - S723
  • [27] Ovarian stimulation: Possible increased malignancy risk
    Cordes T.
    Griesinger G.
    Diedrich K.
    Schultze-Mosgau A.
    Der Gynäkologe, 2010, 43 (4): : 335 - 340
  • [28] THE INCREASED RISK OF DEVELOPING TUBERCULOSIS IN CHILDREN WITH MALIGNANCY
    WESSELS, G
    HESSELING, PB
    GIE, RP
    NEL, E
    ANNALS OF TROPICAL PAEDIATRICS, 1992, 12 (03): : 277 - 281
  • [29] IS ANKYLOSING SPONDYLITIS ASSOCIATED WITH INCREASED MALIGNANCY RISK?
    Merjanah, S.
    Bittar, M.
    Magrey, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1645 - 1645
  • [30] Are DMARDs associated with increased risk of infection in RA?
    Lacaille, D
    Anis, A
    Esdaile, J
    Guh, D
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S674 - S675
12345